Sonnet BioTherapeutics Holdings, Inc. - COM (SONN)

Historical Portfolio Holders from Q3 2023 to Q3 2024

All holders as of June 30, 2024
Q2 2024
Type / Class
Equity / COM
Shares, excl. options Q2 2024
586K
Holdings value Q2 2024
$550K
Value change Q2 2024
+$459K
Grand Portfolio weight change Q2 2024
+0%
Number of holders
11
Number of buys Q2 2024
0
Number of sells Q2 2024
-1
Average buys Q2 2024 %
0
Average sells Q2 2024 %
0%
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors
Period Shares, Excl. Options Value, Excl. Options Change Price Investors
2024 Q3 0 $0 -$3 0
2024 Q2 586K $550K +$459K $0.94 11
2024 Q1 63.3K $118K -$42.3K $1.86 10
2023 Q4 90.8K $158K +$86.9K $1.74 10
2023 Q3 38.3K $110K +$110K $2.87 10